Elektrofi is working on
the next generation of delivery
In 2016, Elektrofi's MIT-based founding team combined its roots in rocket science and biochemistry to develop a proprietary drug delivery platform. Elektrofi is a privately-owned, preclinical-stage company engaged in early-stage partnerships.
We envision a future where patients will have greater access to life-saving therapeutics through increased competition and higher throughput at hospitals. Ultimately, Elektrofi will improve the lives of patients by transforming drug delivery.
We are fortunate to have some outstanding partners including: